loadpatents
name:-0.011207103729248
name:-0.013501882553101
name:-0.00043392181396484
Shawver; Laura K. Patent Filings

Shawver; Laura K.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shawver; Laura K..The latest application filed is for "immunotoxins directed against c-erbb-2(her-2/neu) related surface antigens".

Company Profile
0.8.4
  • Shawver; Laura K. - San Francisco CA
  • Shawver; Laura K. - Alameda CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Immunotoxins directed against c-erbB-2(HER-2/neu) related surface antigens
Grant 7,754,211 - Rosenblum , et al. July 13, 2
2010-07-13
Method and compositions for inhibiting cell proliferative disorders
Grant 7,217,737 - Chen , et al. May 15, 2
2007-05-15
Immunotoxins directed against c-erbB-2(HER-2/neu) related surface antigens
App 20050163774 - Rosenblum, Michael ;   et al.
2005-07-28
Use of ligand-mimicking agents and anti-neoplastic drugs in cancer therapy
Grant 6,884,418 - Shawver , et al. April 26, 2
2005-04-26
Method and compositions for inhibiting cell proliferative disorders
App 20040242684 - Chen, Hui ;   et al.
2004-12-02
Methods and compositions for inhibiting cell proliferative disorders
Grant 6,596,878 - Chen , et al. July 22, 2
2003-07-22
3-heteroarylidenyl-2-indolinone Compounds For Modulating Protein Kinase Activity And For Use In Cancer Chemotherapy
App 20030073837 - LANGECKER, PETER J. ;   et al.
2003-04-17
Methods and compositions for inhibiting cell proliferative disorders
App 20020068687 - Chen, Hui ;   et al.
2002-06-06
Anti-neoplastic drugs in cancer therapy
Grant 6,123,939 - Shawver , et al. September 26, 2
2000-09-26
Methods and compositions for inhibiting cell proliferative disorders
Grant 5,789,427 - Chen , et al.
1998-08-04
Methods and compositions for inhibiting cell proliferative disorders
Grant 5,773,476 - Chen , et al. June 30, 1
1998-06-30
Formulations for lipophilic compounds
Grant 5,610,173 - Schwartz , et al. March 11, 1
1997-03-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed